Clin2
NCT06221046Possibly a fitNot yet recruiting

Barrier cream for skin damage from diarrhea

Moisture Associated Skin DamageIncontinence Associated DermatitisFecal Incontinence

Part of Digestive system clinical trials.

This trial tests a new barrier cream to treat skin irritation caused by diarrhea or stool leakage. It aims to see if the cream is safe and helps heal the skin better than standard care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have skin irritation (a rash) caused by diarrhea or stool leakage.
  • You are expected to stay in the hospital for at least two weeks.
  • You are able to give permission for the study, and you agree to have daily photos taken of the rash.
  • You do not have other serious skin conditions like psoriasis or eczema, or a bacterial skin infection.
  • You are not allergic to any ingredient in the study cream.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06370637Not yet recruiting
Testing a protective cream for stool-related rash

This study tests a new protective cream for a rash caused by diarrhea or stool leakage. The cream is meant to soothe and protect your skin in that area, potentially helping it heal and stay comfortable.

Calgary, Alberta
NCT07524439Recruiting
Beta-glucan cream for incontinence-related skin irritation

This study tests whether a special cream containing beta-glucan (a natural ingredient) can soothe and protect skin damaged by urine or stool leakage. You'd apply the cream during a hospital stay of at least one week to see if it helps healing.

Edmonton, Alberta
NCT06644027Not yet recruiting
Preventing skin rash from incontinence in intensive care

This study tests a new approach to preventing a common skin rash (incontinence-associated dermatitis) in ICU patients who have incontinence. If you qualify, the trial will help keep your skin healthy and comfortable while you’re in the hospital.

NCT06178289Enrolling by invitation
Skin protectant for moisture damage in hospitals

This trial tests a new skin protectant lotion for people in the hospital with skin damage from moisture (like urine or stool). It aims to see if the lotion helps heal these wounds better than current care.

Antwerp
NCT07633808Not yet recruiting
Breast milk vs. barrier cream for baby diaper rash

This study compares using mother's breast milk against using a barrier cream to treat diaper rash in babies up to 24 months old. It aims to find which method works better for healing the rash.

Tulkarm, Tulkarm
NCT07851519Enrolling by invitation
Skin barrier spray for pressure injury prevention in incontinent older adults

This study tests a moisturizing skin care routine with a barrier spray to prevent bedsores in older adults who have trouble controlling their bladder or bowels. If you are 65 or older and have some skin intact, this could help you stay healthy.

Hong Kong

Hear when a new Incontinence Associated Dermatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.